FRESENIUS SE+CO. ADR 1/4 Cash Flow Conversion Efficiency
FRESENIUS SE+CO. ADR 1/4 cash flow conversion efficiency. Based on the latest financial reports, FRESENIUS SE+CO. ADR 1/4 (FREA) has a cash flow conversion efficiency ratio of 0.068x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.34 Billion ≈ $1.57 Billion USD) by net assets (€19.77 Billion ≈ $23.11 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see FREA market cap for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of FRESENIUS SE+CO. ADR 1/4 (2021–2025)
Cash flow conversion efficiency of FRESENIUS SE+CO. ADR 1/4 from 2021 to 2025. This chart illustrates how FRESENIUS SE+CO. ADR 1/4's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest FRESENIUS SE+CO. ADR 1/4 stock price today for real-time trading data and today's change.
FRESENIUS SE+CO. ADR 1/4 Cash Flow Conversion Ratio Explained
FRESENIUS SE+CO. ADR 1/4 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
FRESENIUS SE+CO. ADR 1/4 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of FRESENIUS SE+CO. ADR 1/4 ranked by their cash flow conversion efficiency. Review FRESENIUS SE+CO. ADR 1/4 free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Estee Lauder Companies Inc
NYSE:EL
|
0.103x |
|
Dollar General Corporation
NYSE:DG
|
0.081x |
|
Bank Hapoalim
TA:POLI
|
0.164x |
|
Citizens Financial Group, Inc.
NYSE:CFG
|
0.028x |
|
Dover Corporation
NYSE:DOV
|
0.026x |
|
Ecopetrol SA ADR
NYSE:EC
|
0.050x |
|
American Water Works
NYSE:AWK
|
0.052x |
|
SIKA AG UNSP.ADR O.N.
F:SIKB
|
N/A |
Annual Cash Flow Conversion Efficiency for FRESENIUS SE+CO. ADR 1/4 (2021–2025)
The table below shows the annual cash flow conversion efficiency of FRESENIUS SE+CO. ADR 1/4 from 2021 to 2025. Also see FREA current and non-current assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €19.77 Billion ≈ $23.11 Billion |
€2.57 Billion ≈ $3.01 Billion |
0.130x | +7.97% |
| 2024-12-31 | €20.29 Billion ≈ $23.72 Billion |
€2.45 Billion ≈ $2.86 Billion |
0.121x | -46.81% |
| 2023-12-31 | €19.65 Billion ≈ $22.97 Billion |
€4.46 Billion ≈ $5.21 Billion |
0.227x | +74.03% |
| 2022-12-31 | €32.22 Billion ≈ $37.67 Billion |
€4.20 Billion ≈ $4.91 Billion |
0.130x | -24.85% |
| 2021-12-31 | €29.29 Billion ≈ $34.24 Billion |
€5.08 Billion ≈ $5.94 Billion |
0.173x | -- |
About FRESENIUS SE+CO. ADR 1/4
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machin… Read more